PATENT CLAIM ANALYSIS

Application Number: 16272508
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "428000"]

Abstract:
Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants may be placed in an eye to treat one or more ocular conditions, such as an ocular vasculopathy or glaucoma, among others.

Claim (Index 45):
The method of  claim 44 , wherein the implant is placed in the vitreous cavity of the eye.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 99.0
- Lexical Diversity: 1.85417
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12024017', '12024014', '14886376', '12024010', '11119021']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8685128762097389
- 35 USC 102 Novelty (BERT): 0.5763447733661776
- Combined Prediction Score: 0.8392960659253829
- Mean Citation Score: 652.9837259999998
- Max Citation Score: 684.8945
- Similarity Product: 372.2309390216768

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test